NO931364L - Tachykinin reseptorantagonister, isokinoloner og deres fremstilling - Google Patents
Tachykinin reseptorantagonister, isokinoloner og deres fremstillingInfo
- Publication number
- NO931364L NO931364L NO93931364A NO931364A NO931364L NO 931364 L NO931364 L NO 931364L NO 93931364 A NO93931364 A NO 93931364A NO 931364 A NO931364 A NO 931364A NO 931364 L NO931364 L NO 931364L
- Authority
- NO
- Norway
- Prior art keywords
- tachykinine
- isoqinolons
- preparation
- receptor antagonists
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9529192 | 1992-04-15 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO931364D0 NO931364D0 (no) | 1993-04-14 |
| NO931364L true NO931364L (no) | 1993-10-18 |
| NO179550B NO179550B (no) | 1996-07-22 |
| NO179550C NO179550C (no) | 1996-10-30 |
Family
ID=14133676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO931364A NO179550C (no) | 1992-04-15 | 1993-04-14 | Tachykinin reseptorantagonister |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5523305A (no) |
| EP (1) | EP0566069A1 (no) |
| KR (1) | KR930021202A (no) |
| CN (1) | CN1083054A (no) |
| AU (1) | AU657045B2 (no) |
| CA (1) | CA2094117A1 (no) |
| FI (1) | FI931682A (no) |
| HU (1) | HUT70148A (no) |
| NO (1) | NO179550C (no) |
| NZ (1) | NZ247302A (no) |
| TW (1) | TW241258B (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0634402A1 (en) * | 1993-07-14 | 1995-01-18 | Takeda Chemical Industries, Ltd. | Isochinolinone derivatives, their production and use |
| TW263498B (no) * | 1993-11-10 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
| EP0733632B1 (en) * | 1995-03-24 | 2003-06-04 | Takeda Chemical Industries, Ltd. | Cyclic compounds, their production and use as tachykinin receptor antagonists |
| US5770590A (en) * | 1995-03-24 | 1998-06-23 | Takeda Chemical Industries, Ltd. | Cyclic compounds, their prudiction and use |
| AU2003211931A1 (en) * | 2002-02-13 | 2003-09-04 | Takeda Chemical Industries, Ltd. | Jnk inhibitor |
| AU2004276268B2 (en) * | 2003-09-23 | 2009-01-29 | Merck Sharp & Dohme Corp. | Isoquinoline potassium channel inhibitors |
| CA2539541C (en) * | 2003-09-23 | 2010-06-29 | Merck & Co., Inc. | Isoquinolinone potassium channel inhibitors |
| ES2672099T3 (es) | 2011-07-04 | 2018-06-12 | Irbm - Science Park S.P.A. | Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal |
| EP4371613A3 (en) | 2018-02-26 | 2024-07-24 | Ospedale San Raffaele S.r.l. | Compounds for use in the treatment of ocular pain |
| WO2021180885A1 (en) | 2020-03-11 | 2021-09-16 | Ospedale San Raffaele S.R.L. | Treatment of stem cell deficiency |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2647902A (en) * | 1951-02-16 | 1953-08-04 | Smith Kline French Lab | Method for the preparation of tetrahydroisoquinolone derivatives |
| US2809969A (en) * | 1955-11-07 | 1957-10-15 | Bristol Lab Inc | Isoquinolone derivatives |
| US3247212A (en) * | 1963-03-19 | 1966-04-19 | Dow Chemical Co | Thio substituted 3 amino isoquinolines |
| US3600394A (en) * | 1968-05-17 | 1971-08-17 | Searle & Co | 2-aminoalkyl-3-arylisocarbostyrils |
| DE2030675A1 (en) * | 1969-06-23 | 1971-02-11 | Arthur D Little, Inc , Cambridge, Mass (V St A) | 3-amino-4-phenyl-isoquinoline derivs |
| IL45823A (en) * | 1973-10-20 | 1977-10-31 | Hoechst Ag | Substituted 1-phenyl-4-alkyl(dialkyl or cyclic) aminoalkyl-1,4-dihydro-2h-isoquinoline-3-one derivatives |
| TW205037B (no) * | 1989-10-06 | 1993-05-01 | Takeda Pharm Industry Co Ltd | |
| JPH03181465A (ja) * | 1989-12-11 | 1991-08-07 | Takeda Chem Ind Ltd | キノリン誘導体 |
| US5143919A (en) * | 1990-08-17 | 1992-09-01 | Takeda Chemical Industries, Ltd. | Thienopyridine derivatives and their pharmaceutical use |
| JPH059179A (ja) * | 1990-09-27 | 1993-01-19 | Takeda Chem Ind Ltd | 複素環化合物、その製造法及びａｃａｔ阻害剤 |
| DE69110828T2 (de) * | 1990-10-16 | 1995-11-30 | Takeda Chemical Industries Ltd | Heterozyklische Aminderivate, deren Herstellung und deren Verwendung. |
-
1993
- 1993-03-30 TW TW082102343A patent/TW241258B/zh active
- 1993-03-31 NZ NZ247302A patent/NZ247302A/en unknown
- 1993-04-01 AU AU35663/93A patent/AU657045B2/en not_active Ceased
- 1993-04-13 US US08/045,219 patent/US5523305A/en not_active Expired - Fee Related
- 1993-04-14 FI FI931682A patent/FI931682A/fi not_active Application Discontinuation
- 1993-04-14 NO NO931364A patent/NO179550C/no unknown
- 1993-04-14 HU HU9301080A patent/HUT70148A/hu unknown
- 1993-04-14 KR KR1019930006221A patent/KR930021202A/ko not_active IP Right Cessation
- 1993-04-14 EP EP93106015A patent/EP0566069A1/en not_active Withdrawn
- 1993-04-15 CN CN93105950A patent/CN1083054A/zh active Pending
- 1993-04-15 CA CA002094117A patent/CA2094117A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW241258B (no) | 1995-02-21 |
| AU657045B2 (en) | 1995-02-23 |
| NO179550C (no) | 1996-10-30 |
| FI931682A0 (fi) | 1993-04-14 |
| KR930021202A (ko) | 1993-11-22 |
| NO179550B (no) | 1996-07-22 |
| HUT70148A (en) | 1995-09-28 |
| CA2094117A1 (en) | 1993-10-16 |
| NZ247302A (en) | 1994-12-22 |
| FI931682A (fi) | 1993-10-16 |
| CN1083054A (zh) | 1994-03-02 |
| NO931364D0 (no) | 1993-04-14 |
| EP0566069A1 (en) | 1993-10-20 |
| AU3566393A (en) | 1993-10-21 |
| HU9301080D0 (en) | 1993-06-28 |
| US5523305A (en) | 1996-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI952064A (fi) | Takykiniinireseptoriantagonisteja, joilla ei ole peptidyylirakennetta | |
| NO961160L (no) | Cykliske forbindelser, deres fremstilling og anvendelse | |
| FI961804A0 (fi) | Endoteliinireseptoriantagonistit | |
| NO972526D0 (no) | Tachykininantagonister | |
| DK0523183T3 (da) | Mikrosfærer, deres fremstilling og anvendelse | |
| DE69327720D1 (de) | Endothelin rezeptor antagonisten | |
| DK1019358T3 (da) | 3,3-diarylpropylaminer, deres anvendelse og fremstilling | |
| BR9406572A (pt) | Antagonistas receptores do endotelin | |
| NO931364D0 (no) | Tachykinin reseptorantagonister, isokinoloner og deres fremstilling | |
| NO930709L (no) | Nye cholecystokinin-antagonister, deres fremstilling og terapeutiske anvendelse | |
| NO941517L (no) | 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse | |
| NO954763D0 (no) | Piperidinderivater, deres fremstilling og anvendelse | |
| DK199989D0 (da) | Angucyclinoner fra streptomyceter, deres fremstilling og anvendelse | |
| NO974057D0 (no) | Bisykliske takykinin-antagonister, fremstilling derav og deres anvendelse i farmasöytisk sammensetning | |
| DK614088D0 (da) | Fluormethoxyphenyl-dihydropyridiner, deres fremstilling og anvendelse | |
| DK73091D0 (da) | Quinoxalinforbindelser, deres fremstilling og anvendelse | |
| NO973230D0 (no) | Nye peptider, deres fremstilling og anvendelse | |
| NO179073C (no) | Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse | |
| DK196389A (da) | N-substituerede n-amino-pyrroler, deres fremstilling og anvendelse | |
| DK25989D0 (da) | 4-alkyl-1,4-dihydropyridiner samt deres fremstilling og anvendelse | |
| DK202089D0 (da) | Angucyclinoner fra streptomyceter, deres fremstilling og anvendelse | |
| DK613988D0 (da) | Fluormethoxyphenyl-dihydropyridiner, deres fremstilling og anvendelse | |
| DK55893D0 (da) | Nye receptoraktive forbindelser, deres fremstilling og anvendelse | |
| DK145489D0 (da) | 2,6-methano-1,3-benzodiazociner, deres fremstilling og anvendelse som analgetika | |
| NO920228L (no) | Polylaktider, deres fremstilling og anvendelse |